Cite

    Peyrin-Biroulet, L., Parkes, G., Rodríguez, C., Siffledeen, J., Wright, J., Broide, E., Ford, S., Lacerda, A. P., Oomen, J., Garrison, A., Berg, S., & Rubin, D. T. (n.d.). oP16 Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics. Journal of Crohn's and colitis, 17, i20–i22. http://access.bl.uk/ark:/81055/vdc_100179866055.0x00001c